shortage of glp 1 The GLP-1 boom created one the strangest health stories of the decade. Drugs built for diabetes and obesity became pop-culture products, then supply shortages opened the door to falsified versions. WHO What happens when demand outpaces

As such, some patients may begin seeing weight loss within a week or two after starting treatment

NICE guidance (NG28) recommends GLP-1 receptor agonists for type 2 diabetes in specific clinical circumstances, typically when metformin and other treatments have not achieved glycaemic targets

As a result of that, initial recommendations focus on the use of metformin or a thiazolidinedione if metformin is contraindicated, followed by a GLP-1 agonist or a DPP-4 inhibitor

Leggio is Chief of the joint NIDA/NIAAA Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section

The way these drugs work, in part, is making you feel full quickly, so you wind up eating less, which is what spurs weight loss